BETTERLIFE PHARMA INC. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
BETTERLIFE PHARMA INC. (BETRF) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of 0.17 CAD/shares for the 12-month period ending 2023-01-31, per its 20-F/A filed 2023-06-06.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2023-06-06
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2023-01-31 | 0.17 CAD/shares 20-F/A · filed 2023-06-06 | |
| 2022-01-31 | 0.48 CAD/shares 20-F/A · filed 2023-06-06 | |
| 2021-01-31 | 1.03 CAD/shares 20-F/A · filed 2023-06-06 | |
| 2020-01-31 | 3.19 CAD/shares 20-F · filed 2022-06-06 | |
| 2019-01-31 | 12.50 CAD/shares 20-F/A · filed 2021-06-23 | 0.32 CAD/shares 20-F/A · filed 2020-06-05 |
| 2018-01-31 | 1.25 CAD/shares 20-F/A · filed 2020-06-05 |